title: What potential do aptamers hold in therapeutic delivery?
authors.affiliation: School of Medicine, Deakin University, Geelong, Victoria, Australia.|Centre for Molecular & Medical Research, Deakin University, Geelong, Victoria, Australia.
authors.forename: Sarah
authors.initials: S
authors.lastname: Shigdar
mesh_terms: D000818:Animals; D000906:Antibodies / Q000737:chemistry; D052157:Aptamers, Nucleotide / Q000737:chemistry*; D004317:Doxorubicin / Q000737:chemistry / Q000627:therapeutic use; D004337:Drug Carriers / Q000737:chemistry*; D009369:Neoplasms / Q000188:drug therapy; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D052156:SELEX Aptamer Technique
chemical_list: D000906:Antibodies; D052157:Aptamers, Nucleotide; D004337:Drug Carriers; D034741:RNA, Small Interfering; D004317:Doxorubicin
keywords: antibodies; aptamers; chemical antibodies; drug delivery; therapeutic delivery